PetMedix is a pet therapeutics startup.
PetMedix has raised €31M across 1 funding round from 6 investors, most recently a Series B round in Sep 2021. Based in Cambridge, UK; active in Consumer. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-08 | Series B |
| €31M |
| Additionally,Cambridge Innovation Capital,Digitalis Ventures,Kyoritsu Holdings,Parkwalk Advisors,Tencent |
| View deal → |
